GPX4 and myeloid sarcoma: Similar to the loss of GPX4 by OLIG2+ cells in the OxPC and LPC lesions, there was a trend towards GPX4 reduction in the inactive core and chronic active rim of the MS lesions compared to the control WM (Fig. 5C).